BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19356748)

  • 1. Semantic activation in Parkinson's disease patients on and off levodopa.
    Angwin AJ; Arnott WL; Copland DA; Haire MP; Murdoch BE; Silburn PA; Chenery HJ
    Cortex; 2009 Sep; 45(8):950-9. PubMed ID: 19356748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
    Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
    Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summation of semantic priming and complex sentence comprehension in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    Brain Res Cogn Brain Res; 2005 Sep; 25(1):78-89. PubMed ID: 15894470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The speed of lexical activation is altered in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spreading activation of lexical-semantic networks in Parkinson's disease.
    Foster PS; Drago V; FitzGerald DB; Skoblar BM; Crucian GP; Heilman KM
    Neuropsychologia; 2008; 46(7):1908-14. PubMed ID: 18325544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease.
    Castner JE; Chenery HJ; Copland DA; Coyne TJ; Sinclair F; Silburn PA
    Brain; 2007 May; 130(Pt 5):1395-407. PubMed ID: 17430981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Word processing in Parkinson's disease is impaired for action verbs but not for concrete nouns.
    Boulenger V; Mechtouff L; Thobois S; Broussolle E; Jeannerod M; Nazir TA
    Neuropsychologia; 2008 Jan; 46(2):743-56. PubMed ID: 18037143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of inhibition in Parkinson's disease: evidence from a lexical decision task.
    MarĂ­-Beffa P; Hayes AE; Machado L; Hindle JV
    Neuropsychologia; 2005; 43(4):638-46. PubMed ID: 15716153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semantic and cross-case identity priming in patients with Parkinson's disease.
    Filoteo JV; Friedrich FJ; Rilling LM; Davis JD; Stricker JL; Prenovitz M
    J Clin Exp Neuropsychol; 2003 Jun; 25(4):441-56. PubMed ID: 12911099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired semantic inhibition during lexical ambiguity repetition in Parkinson's disease.
    Copland DA; Sefe G; Ashley J; Hudson C; Chenery HJ
    Cortex; 2009 Sep; 45(8):943-9. PubMed ID: 19393992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa improves time-based prospective memory in Parkinson's disease.
    Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
    J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment.
    Righi S; Viggiano MP; Paganini M; Ramat S; Marini P
    Neuropsychologia; 2007 Oct; 45(13):2931-41. PubMed ID: 17662314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease.
    Relja M; Klepac N
    J Neurol Sci; 2006 Oct; 248(1-2):251-4. PubMed ID: 16797593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.